Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:Parp Inhibitor,High Purity Parp Inhibitor,Pharmaceutical Grade Parp Inhibitor
Conbott Pharmtech Co.,Ltd. Parp Inhibitor,High Purity Parp Inhibitor,Pharmaceutical Grade Parp Inhibitor
Home > Products > Inhibitors > PARP Inhibitor
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

PARP Inhibitor

Product categories of PARP Inhibitor, we are specialized manufacturers from China, Parp Inhibitor, High Purity Parp Inhibitor suppliers/factory, wholesale high-quality products of Pharmaceutical Grade Parp Inhibitor R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!
View: List Grid
Trifluridine Intermediate 3,4-Dihydro-2H-pyrrol-5-amine hydrochloride CAS 7544-75-4
Trifluridine Intermediate 3,4-Dihydro-2H-pyrrol-5-amine hydrochloride CAS 7544-75-4

Model No. : 7544-75-4

2-Amino-1-pyrroline hydrochloride CAS No.7544-75-4 is offered with high quality and attractive price. 2-Amino-1-pyrroline hydrochloride CAS 7544-75-4 has the molecular formula of C4H9ClN2. 2-Amino-1-pyrroline hydrochloride also called...

China Manufacturer of Parp Inhibitor
Ixazomib (MLN9708) Intermediate N-[(2,5-dichlorophenyl)carbonyl]glycine 667403-46-5
Ixazomib (MLN9708) Intermediate N-[(2,5-dichlorophenyl)carbonyl]glycine 667403-46-5

Model No. : 667403-46-5

We supply high quality product of N-[(2,5-dichlorophenyl)carbonyl]glycine CAS No.667403-46-5 with attractive price.N-[(2,5-dichlorophenyl)carbonyl]glycine also called CHEMBRDG-BB 7959525 CAS 667403-46-5 has the molecular formula of...

High Quality High Purity Parp Inhibitor China Supplier
Anti Cancer Pharmaceutical Rucaparib(AG-014699, PF-01367338) Intermediate 1408282-26-7
Anti Cancer Pharmaceutical Rucaparib(AG-014699, PF-01367338) Intermediate 1408282-26-7

Model No. : 1408282-26-7

8-Fluoro-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one is offered with high quality and attractive price by our company. 8-Fluoro-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one also called...

Professional Manufacturer of Pharmaceutical Grade Parp Inhibitor
2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one 283173-80-8
2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one 283173-80-8

Model No. : 283173-80-8

We provide large quantity of 2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one CAS No.283173-80-8 with high purity.It also called 2-Bromo-8-fluoro-1,3,4,5-tetrahydro-6H-azepi -no[5,4,3-cd]indol-6-one CAS 283173-80-8 has the molecular...

Expert Manufacturer of Parp Inhibitor
Potent PARP Inhibitor Veliparib (ABT-888) CAS 912444-00-9
Potent PARP Inhibitor Veliparib (ABT-888) CAS 912444-00-9

Model No. : 912444-00-9

Veliparib (ABT-888) CAS No.912444-00-9 is a potent, orally bioavailable PARP-1/-2 inhibitor, which is shown to potentiate DNA damaging agents. We supply high quality product of Veliparib (ABT-888) CAS 912444-00-9 with a largre inventory. We are...

China Supplier of High Purity Parp Inhibitor
(R)-1-(Benzyloxycarbonyl)-2-Methylpyrrolidine-2-Carboxylic Acid CAS 63399-74-6
(R)-1-(Benzyloxycarbonyl)-2-Methylpyrrolidine-2-Carboxylic Acid CAS 63399-74-6

Model No. : 63399-74-6

We are able to supply large quantity of (R)-1-(Benzyloxycarbonyl)-2-Methylpyrrolidine-2-carboxy -lic acid CAS No.63399-74-6 to meet your emergency requirement.(R)-1-(Benzyloxycarbonyl)-2 -Methylpyrrolidine-2-carboxylic acid CAS 63399-74-6 is one of...

China Factory of Pharmaceutical Grade Parp Inhibitor
High Effective PARP Inhibitor ABT-888 Intermediates CAS 166170-15-6
High Effective PARP Inhibitor ABT-888 Intermediates CAS 166170-15-6

Model No. : 166170-15-6

Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM in cell-free assays, respectively. We can provide a large number of premium quality Veliparib Intermediates CAS 166170-15-6 for our clients. Processed...

Parp Inhibitor Export
(R)-N-BOC-2-Methylproline CAS 166170-15-6
(R)-N-BOC-2-Methylproline CAS 166170-15-6

Model No. : 166170-15-6

(R)-N-BOC-2-Methylproline CAS 166170-15-6 is an important product in our company. We can offer a range of high purity (R)-N-BOC-2-Methylproline 166170-15-6 that is always used to synthesis Veliparib(also called ABT-888). As a PARP inhibitor,...

Competitive High Purity Parp Inhibitor China Supplier

China PARP Inhibitor Suppliers

PARP Inhibitors can affect self-replication of cancer cells. In addition to breast cancer, the drug can also treat ovarian cancer, prostate cancer and pancreatic cancer and other hereditary cancers have the same "rogue gene". In 2011 British scientists say, a drug to treat breast cancer can be transformed into a fight against various cancers "universal weapon." During the study, the research team found a way to be able to make breast cancer drug effective in the treatment of other cancers. In addition, this new drug may cause nausea and reduce other side effects of nausea and fatigue to a minimum level. This magical breast cancer is called "PARP inhibitors." PARP inhibitors work by inhibiting tumor cell DNA damage repair, promote tumor cell apoptosis, which can enhance the efficacy of radiotherapy and alkylating agents and platinum-based chemotherapy.
The drug use hereditary breast cancer "Achilles' heel", This weakness is called the "BRCA1" genetic defect, limit the ability of cancer cells to repair damaged DNA. This new drug brings hope for the treatment of refractory cancer, such as well-differentiated ovarian cancer and triple-negative breast cancer. In addition to improve the efficacy of chemotherapy drugs, Parp Inhibitor is effective as a single agent for patients with BRCA mutations. Patients with BRCA mutation has loss of gene recombination function, and through Parp inhibitor to inhibit the DNA repair DNA,Then kill tumor cells by the dual role of preliminary, clinical studies have confirmed this hypothesis. PARP inhibitors not only with the BRCA1 or BRCA2 mutations produce a synergistic effect, but also exisit killing effect of some undiscovered gene mutations.
However, PARP inhibitors is impossible to have no toxic, which also need to be keep vigilant.

Conbottpharm could give you:
1. Best quality in your requirement
2. Competitive price in China market
3. Mature Technical support
4. Professional logistic support
All we want is win-win business. Send yr. inquiries, you will get it!
Copyright © 2018 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?